Sign in
4

Changes in Ownership

BIOCRYST PHARMACEUTICALS INC Filed Acc 0001127602-24-029971

Chief Commercial Officer gave up 2,461 shares (to pay taxes)

  • Chief Commercial Officer acquired 125,950 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Gayer Charles K · Chief Commercial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2024-12-19 Grant or award : show line 1 in the form +125,950 426,007 D
2024-12-19 Shares withheld for taxes : show line 2 in the form −2,461 $7.39 $18,187 423,546 D

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2024-12-19 Grant or award : show line 3 in the form Emp. Stock Option (Right to Buy) +260,950 260,950 D
Loading xslF345X05/form4.xml…